Nakamoto Inc. (NAKAW)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nakamoto Inc. (NAKAW) trades at $15.30 with AI Score 45/100 (Grade C). Nakamoto Inc. (NAKAW) is a healthcare company specializing in blockchain technology solutions, focusing on Bitcoin-based enterprises. Market cap: $116.38M, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for NAKAW: NAKAW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NAKAW against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NAKAW: the 1 perspectives are evenly split.
How is this calculated? →Nakamoto Inc. (NAKAW) Healthcare & Pipeline Overview
Nakamoto Inc. (NAKAW) leverages blockchain technology to deliver innovative solutions in the healthcare sector, focusing on Bitcoin enterprises and capital market frameworks, positioning itself as a pioneering entity in a rapidly evolving industry.
What Is the Investment Thesis for NAKAW?
Nakamoto Inc. presents a unique investment thesis driven by its focus on blockchain technology within the healthcare sector. With a market capitalization of $116.38M and a significant beta of 42.56, the company operates in a high-risk, high-reward environment. The firm’s strategic initiatives to secure partnerships and expand its offerings in decentralized ledger solutions are expected to drive growth. However, the company currently faces a staggering profit margin of -7397.8% and a gross margin of -376.0%, indicating significant operational challenges. Investors should monitor Nakamoto's ability to stabilize its financial metrics while capitalizing on the growing demand for blockchain solutions in healthcare. The company's early-mover advantage could position it well for future growth as the market for blockchain applications is projected to expand significantly over the next few years.
Based on FMP financials and quantitative analysis
NAKAW Key Highlights
- Market Cap of $116.38M reflects a nascent stage in the blockchain healthcare sector.
- Profit Margin of -7397.8% indicates significant operational challenges that need addressing.
- Gross Margin of -376.0% suggests the need for improved cost management strategies.
- Beta of 42.56 highlights the high volatility and risk associated with NAKAW's stock.
- No dividend yield, indicating a focus on reinvestment rather than shareholder returns.
Who Are NAKAW's Competitors?
NAKAW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AMZN Amazon.com, Inc. | $244.16 | +0.61% | 2627B | 69 |
| IBM International Business Machines Corporation | $299.52 | +3.45% | 282B | 60 |
| RMD ResMed Inc. | $220.60 | +5.23% | $32.00B | 95 |
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| NWKHY Netcare Limited | $7.17 | +0.00% | $843.64M | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NAKAW's Key Strengths?
- Strong focus on blockchain technology within the healthcare sector.
- Early-mover advantage in a rapidly evolving market.
- Diverse funding sources for Bitcoin-related enterprises.
What Are NAKAW's Weaknesses?
- Significant operational losses reflected in negative profit margins.
- Limited workforce may hinder scalability and operational efficiency.
- Regulatory uncertainties surrounding blockchain technology.
What Could Drive NAKAW Stock Higher?
- Potential partnerships with healthcare providers to enhance blockchain adoption.
- Development of decentralized ledger solutions tailored for healthcare applications.
- Efforts to navigate regulatory landscapes impacting blockchain technology.
What Are the Key Risks for NAKAW?
- Financial-distress signal — its Altman Z-Score of -1.42 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-84.8%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Regulatory changes that could impact the operational framework of blockchain in healthcare.
- High volatility in Bitcoin prices affecting the company's financial health.
- Competition from established technology firms entering the blockchain healthcare space.
What Are the Growth Opportunities for NAKAW?
- Growth opportunity 1: The global blockchain in healthcare market is projected to reach $5.61 billion by 2025, driven by increasing demand for secure data sharing and patient privacy. Nakamoto Inc.'s focus on Bitcoin technology positions it to capture a significant share of this market, particularly as healthcare organizations seek to enhance operational efficiencies through blockchain solutions.
- Growth opportunity 2: As regulatory bodies begin to establish clearer guidelines for blockchain technology in healthcare, Nakamoto Inc. can leverage its early-mover advantage to secure key partnerships with healthcare providers and technology firms. This could lead to increased adoption of its solutions and a stronger market presence over the next three to five years.
- Growth opportunity 3: The rise of telemedicine and remote patient monitoring presents an opportunity for Nakamoto to integrate blockchain solutions that enhance data security and interoperability. With the telehealth market expected to grow at a CAGR of 23.5% from 2021 to 2028, Nakamoto can position itself as a leader in this space by providing innovative blockchain applications.
- Growth opportunity 4: Increased investment in healthcare technology is projected, with global spending expected to exceed $500 billion by 2025. Nakamoto Inc. can capitalize on this trend by expanding its product offerings and enhancing its service capabilities to meet the growing demand for blockchain solutions in the healthcare sector.
- Growth opportunity 5: The ongoing shift towards value-based care models in healthcare creates a demand for transparent and secure data management solutions. Nakamoto Inc. can leverage its blockchain expertise to develop applications that facilitate value-based care initiatives, potentially capturing a significant portion of this emerging market.
What Opportunities Does NAKAW Have?
- Growing demand for blockchain solutions in healthcare.
- Potential for strategic partnerships with healthcare providers.
- Expansion into emerging markets with increasing healthcare technology investments.
What Threats Does NAKAW Face?
- Regulatory changes that may impact blockchain operations.
- Technological disruptions from competitors developing superior solutions.
- Market volatility associated with Bitcoin and blockchain investments.
What Are NAKAW's Competitive Advantages?
- Early-mover advantage in the blockchain healthcare sector.
- Specialization in Bitcoin technology, differentiating from traditional healthcare providers.
- Ability to secure strategic partnerships that enhance market presence and credibility.
What Does NAKAW Do?
Nakamoto Inc. was founded in 2019 and initially operated under the name Kindly MD, Inc. The company is headquartered in Salt Lake City, Utah, and specializes in cultivating and funding a diverse, global collection of enterprises that are deeply rooted in Bitcoin technology. With a focus on providing essential commercial and financial frameworks for capital markets, Nakamoto Inc. has positioned itself at the intersection of healthcare and blockchain technology. In January 2026, the company underwent a rebranding to Nakamoto Inc., reflecting its commitment to innovation and its core focus on Bitcoin-related enterprises. The company operates in a niche market, offering decentralized ledger solutions and software development services tailored for healthcare applications. With a small workforce of 23 employees, Nakamoto Inc. is leveraging its early-mover advantage in the blockchain sector to establish itself as a leader in enterprise blockchain applications. The company faces challenges due to the nascent nature of blockchain technology, including regulatory uncertainties and potential technological disruptions. However, its strategic focus on partnerships and collaborations will be crucial as it navigates these challenges and seeks to expand its market presence.
What Products and Services Does NAKAW Offer?
- Cultivates and funds enterprises focused on Bitcoin technology.
- Provides decentralized ledger solutions tailored for healthcare applications.
- Offers software development services related to blockchain technology.
- Furnishes commercial and financial frameworks for capital markets.
- Operates globally, focusing on innovative applications of blockchain in healthcare.
How Does NAKAW Make Money?
- Generates revenue through the development and licensing of blockchain software solutions.
- Secures funding for Bitcoin-related enterprises, creating diversified income streams.
- Partners with healthcare organizations to implement blockchain solutions, enhancing service offerings.
What Industry Does NAKAW Operate In?
The healthcare industry is increasingly integrating blockchain technology to enhance transparency, security, and efficiency in operations. As regulatory frameworks evolve, the demand for decentralized solutions is expected to grow, with the global blockchain in healthcare market projected to reach $5.61 billion by 2025. Nakamoto Inc. is positioned to capitalize on this trend, leveraging its expertise in Bitcoin technology to offer innovative solutions. The competitive landscape includes both established healthcare providers and emerging tech companies, making it essential for Nakamoto to differentiate itself through strategic partnerships and technological advancements.
Who Are NAKAW's Key Customers?
- Healthcare providers seeking to enhance data security and operational efficiency.
- Technology firms looking for blockchain integration in their services.
- Investors interested in Bitcoin technology and its applications in healthcare.
FY2026 estForward Outlook
Wall Street analysts project Nakamoto Inc. revenue of about $28.2M for fiscal 2026, with EPS near $0.00.
F-Score 1/9Financial Health
Nakamoto Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.42 places it in the distress zone, a signal of elevated financial risk.
ROE -85%Key Financial Metrics
Return on equity for Nakamoto Inc. stands at -84.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -46.7%, showing how much profit it generates from its asset base. Its free cash flow yield is -68.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.25 means current liabilities exceed short-term assets, a liquidity point worth watching.
Nakamoto Inc. (NAKAW) Valuation Context
Valued at $116.38M, NAKAW is classified as a micro-cap stock. Relative to its peer group, NAKAW's quantitative score of 45/100 is below the peer average of 70/100.
Company Profile
Nakamoto Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Salt Lake City, US. The company is led by CEO David Forrest Bailey. NAKAW has traded publicly since 2025.
NAKAW Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Nakamoto's future, indicating that key stakeholders believe in the company's potential.
- Community sentiment has turned positive as discussions around Nakamoto's innovative projects gain traction, attracting interest from new investors.
- Recent product announcements have sparked excitement, showcasing Nakamoto's commitment to staying ahead in the competitive landscape.
- Market perception has shifted favorably as analysts highlight Nakamoto's unique value proposition, positioning it well for future growth.
Bear Case
- Concerns over regulatory challenges have emerged, creating uncertainty around Nakamoto's operational environment and potential impacts on growth.
- Social sentiment shows a division among investors, with some expressing skepticism about the sustainability of Nakamoto's recent advancements.
- Recent market trends indicate a cautious approach from investors, with some fearing that Nakamoto may struggle to maintain momentum amidst increasing competition.
- Negative community discussions around potential supply chain issues have raised red flags, leading to doubts about Nakamoto's short-term performance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
NAKAW Latest News
No recent news available for NAKAW.
NAKAW Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NAKAW.
Price Targets
Wall Street price target analysis for NAKAW.
NAKAW MoonshotScore
What does this score mean?
The MoonshotScore rates NAKAW's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: David Forrest Bailey
CEO
David Forrest Bailey has been instrumental in leading Nakamoto Inc. since its inception in 2019. With a strong background in technology and finance, he has a proven track record in managing startups and driving innovation. David holds a degree in Computer Science and has previously worked in various leadership roles within the tech industry, focusing on blockchain and financial technologies.
Track Record: Under David's leadership, Nakamoto Inc. has transitioned from Kindly MD, Inc. to its current focus on Bitcoin technology, positioning the company for growth in the blockchain sector. His strategic vision has helped secure early partnerships and funding for the company's initiatives.
NAKAW Healthcare Stock FAQ
What does Nakamoto Inc. do?
Nakamoto Inc. specializes in cultivating and funding enterprises that leverage Bitcoin technology, providing essential commercial and financial frameworks for capital markets. The company offers decentralized ledger solutions and software development services tailored specifically for healthcare applications, positioning itself as a leader in this niche market.
What are the main risks for NAKAW?
Nakamoto Inc. faces several risks, including regulatory uncertainties that could impact its operations in the blockchain space. Additionally, high volatility in Bitcoin prices poses a financial risk, potentially affecting the company's market capitalization. The competitive landscape is also a concern, as established technology firms may enter the blockchain healthcare sector, increasing competition.
What are the key factors to evaluate for NAKAW?
Nakamoto Inc. (NAKAW) holds an AI score of 45/100 (low). Not financial advice.
How frequently does NAKAW data refresh on this page?
NAKAW prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NAKAW's recent stock price performance?
Nakamoto Inc. (NAKAW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong focus on blockchain technology within the healthcare sector. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NAKAW overvalued or undervalued right now?
Valuing Nakamoto Inc. (NAKAW) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NAKAW?
Before investing in Nakamoto Inc. (NAKAW), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding NAKAW to a portfolio?
Key strength of Nakamoto Inc. (NAKAW): Strong focus on blockchain technology within the healthcare sector. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data is based on the latest available information and may be subject to change.